Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Completed · Phase 2

Conditions studied: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

In brief

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylactic treatment with NovoSeven® in haemophilia A and B patients with inhibitors.

Key facts

Study ID

NCT00108758

Run by

Novo Nordisk A/S

People needed

23

Starts

2004-03-01

Expected to finish

2005-11-01

Last updated by the study team

2017-01-12

Who can join

Age: 2 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of congenital haemophilia A or B with inhibitors development against FVIII or FIX, respectively

You may not qualify if…

• Prophylactic administration of any haemostatic drug within 3 last months prior to entering the trial.

Where it is running

• Novo Nordisk Investigational Site — Berkeley, California, United States
• Novo Nordisk Investigational Site — Los Angeles, California, United States
• Novo Nordisk Investigational Site — Chicago, Illinois, United States
• Novo Nordisk Investigational Site — Indianapolis, Indiana, United States
• Novo Nordisk Investigational Site — Iowa City, Iowa, United States
• Novo Nordisk Investigational Site — New Orleans, Louisiana, United States
• Novo Nordisk Investigational Site — Boston, Massachusetts, United States
• Novo Nordisk Investigational Site — Detroit, Michigan, United States
• Novo Nordisk Investigational Site — Newark, New Jersey, United States
• Novo Nordisk Investigational Site — New Hyde Park, New York, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Houston, Texas, United States
• Novo Nordisk Investigational Site — Ciudad Autónoma de Bs. As., Argentina
• Novo Nordisk Investigational Site — Rio de Janeiro, Rio de Janeiro, Brazil
• Novo Nordisk Investigational Site — Campinas, São Paulo, Brazil
• Novo Nordisk Investigational Site — Belo Horizonte, Brazil
• Novo Nordisk Investigational Site — Recife, Brazil
• Novo Nordisk Investigational Site — Ribeirão Preto, Brazil
• Novo Nordisk Investigational Site — Sofia, Bulgaria
• Novo Nordisk Investigational Site — Le Kremlin-Bicêtre, France
• Novo Nordisk Investigational Site — Lille, France
• Novo Nordisk Investigational Site — Paris, France
• Novo Nordisk Investigational Site — Manila, Philippines
• Novo Nordisk Investigational Site — Gdansk, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.